Oral sebetralstat for on-demand treatment of hereditary angioedema attacks

Authors

Marc A Riedl, University of California - San Diego
H James Wedner, Washington University School of Medicine in St. Louis
et al.

Journal

New England Journal of Medicine

Publication Date

7-4-2024

Volume

391

Issue

1

First Page

32

Last Page

43

Document Type

Open Access Publication

DOI

10.1056/NEJMoa2314192

Rights and Permissions

Riedl MA, Farkas H, Aygören-Pürsün E, Psarros F, Soteres DF, Staevska M, Cancian M, Hagin D, Honda D, Melamed I, Savic S, Stobiecki M, Busse PJ, Dias de Castro E, Agmon-Levin N, Gower R, Kessel A, Kurowski M, Lleonart R, Grivcheva Panovska V, Wedner HJ, Audhya PK, Hao J, Iverson M, Smith MD, Yea CM, Lumry WR, Zanichelli A, Bernstein JA, Maurer M, Cohn DM; KONFIDENT Investigators. Oral Sebetralstat for On-Demand Treatment of Hereditary Angioedema Attacks. N Engl J Med. 2024 Jul 4;391(1):32-43. doi: 10.1056/NEJMoa2314192. Copyright © 2024 Massachusetts Medical Society. Reprinted with permission.

Recommended Citation

Riedl, Marc A; Wedner, H James; and et al., "Oral sebetralstat for on-demand treatment of hereditary angioedema attacks." New England Journal of Medicine. 391, 1. 32 - 43. (2024).
https://digitalcommons.wustl.edu/oa_4/4582

Department

ICTS (Institute of Clinical and Translational Sciences)

Additional Links

Supplemental material is available for this article at publisher site.